Next Article in Journal
Circulating MicroRNAs as Biomarkers of Acute Stroke
Next Article in Special Issue
Phosphorylation of Histone H2AX in the Mouse Brain from Development to Senescence
Previous Article in Journal
Extracellular Disposal of Tumor-Suppressor miRs-145 and -34a via Microvesicles and 5-FU Resistance of Human Colon Cancer Cells
Previous Article in Special Issue
Neuroprotective Strategies for Traumatic Brain Injury: Improving Clinical Translation
Open AccessArticle

Phenoxybenzamine Is Neuroprotective in a Rat Model of Severe Traumatic Brain Injury

Department of Biomedical and Pharmaceutical Sciences, University of Montana, Missoula, MT 59812, USA
*
Author to whom correspondence should be addressed.
Int. J. Mol. Sci. 2014, 15(1), 1402-1417; https://doi.org/10.3390/ijms15011402
Received: 25 November 2013 / Revised: 1 January 2014 / Accepted: 14 January 2014 / Published: 20 January 2014
(This article belongs to the Special Issue Neuroprotective Strategies 2014)
Phenoxybenzamine (PBZ) is an FDA approved α-1 adrenergic receptor antagonist that is currently used to treat symptoms of pheochromocytoma. However, it has not been studied as a neuroprotective agent for traumatic brain injury (TBI). While screening neuroprotective candidates, we found that phenoxybenzamine reduced neuronal death in rat hippocampal slice cultures following exposure to oxygen glucose deprivation (OGD). Using this system, we found that phenoxybenzamine reduced neuronal death over a broad dose range (0.1 µM–1 mM) and provided efficacy when delivered up to 16 h post-OGD. We further tested phenoxybenzamine in the rat lateral fluid percussion model of TBI. When administered 8 h after TBI, phenoxybenzamine improved neurological severity scoring and foot fault assessments. At 25 days post injury, phenoxybenzamine treated TBI animals also showed a significant improvement in both learning and memory compared to saline treated controls. We further examined gene expression changes within the cortex following TBI. At 32 h post-TBI phenoxybenzamine treated animals had significantly lower expression of pro-inflammatory signaling proteins CCL2, IL1β, and MyD88, suggesting that phenoxybenzamine may exert a neuroprotective effect by reducing neuroinflammation after TBI. These data suggest that phenonxybenzamine may have application in the treatment of TBI. View Full-Text
Keywords: phenoxybenzamine; traumatic brain injury; neuroprotection; morris water maze phenoxybenzamine; traumatic brain injury; neuroprotection; morris water maze
MDPI and ACS Style

Rau, T.F.; Kothiwal, A.; Rova, A.; Rhoderick, J.F.; Poulsen, D.J. Phenoxybenzamine Is Neuroprotective in a Rat Model of Severe Traumatic Brain Injury. Int. J. Mol. Sci. 2014, 15, 1402-1417.

AMA Style

Rau TF, Kothiwal A, Rova A, Rhoderick JF, Poulsen DJ. Phenoxybenzamine Is Neuroprotective in a Rat Model of Severe Traumatic Brain Injury. International Journal of Molecular Sciences. 2014; 15(1):1402-1417.

Chicago/Turabian Style

Rau, Thomas F.; Kothiwal, Aakriti; Rova, Annela; Rhoderick, Joseph F.; Poulsen, David J. 2014. "Phenoxybenzamine Is Neuroprotective in a Rat Model of Severe Traumatic Brain Injury" Int. J. Mol. Sci. 15, no. 1: 1402-1417.

Find Other Styles

Article Access Map by Country/Region

1
Only visits after 24 November 2015 are recorded.
Search more from Scilit
 
Search
Back to TopTop